Tag: FDA approves Zenbexus
New Hope in Multiple Myeloma Treatment as FDA Approves Zenbexus-Based Regimen
The U.S. Food and Drug Administration has granted accelerated approval to Zenbexus(iberdomide), Bristol Myers Squibb's oral cereblon-modulating protein degrader, for use alongside daratumumab and hyaluronidase-fihj and dexamethasone in adults with...